Sign in
Active, not recruitingNo phase

Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN

Key facts

Who runs it
Fondation Ophtalmologique Adolphe de Rothschild
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
230 people enrolled
Started
20 Dec 2017
Expected to end
23 Jun 2033
Type of study
Observational
Treatments tested
  • Collection of blood sample in aneurysm
Record updated
20 January 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patient aged 18 and over
  • Patient presenting a single or multiple aneurysm
  • Patient presenting an intracranial aneurysm for which an intervention is planned (endovascular treatment or surgery) : elective intervention for an unruptured aneurysm or emergency surgery for a broken aneurysm

Who cannot take part

  • Pregnant or breast feeding woman
  • Patient benefiting from legal protection measures

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sub arachnoid hemorrhage consecutive to intracranial aneurysm rupture is a devastating disease. Predictors of intracranial aneurysm rupture are limited and focus mainly on size and location. Platelet activation may have a deleterious role on aneurysm rupture. The assumption is that patients with ruptured intracranial aneurysm will present a higher rate of platelet activation compared to patients with non ruptured aneurysms.

Treatments tested

  • Collection of blood sample in aneurysm

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 January 2026